Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -14621.00% is 661% below its 1-year average of -1921.94%, near the low end of its 1-year range (-14621.00%–0.00%).
660.74% below its 12-month average of -1921.94%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
-14621.00%
NET PROFIT MARGIN AVG TTM
-1921.94%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
-90.30%
NET PROFIT MARGIN AVG 20Y
-109.84%
CURRENT VS TTM AVG
-660.74%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
-16091.65%
CURRENT VS 20Y AVG
-13210.87%
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-4177328.57%
vs the sector median at left
Lisata Therapeutics, Inc.
Market Cap
$11.02M
Net Profit Margin
-14621.00%
TTM Avg
-1921.94%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$11.00M
Net Profit Margin
N/A
TTM Avg
-2424.09%
3Y Avg
-1624.47%
5Y Avg
-1082.98%
Market Cap
$11.08M
Net Profit Margin
0.00%
TTM Avg
11.23%
3Y Avg
5.62%
5Y Avg
-9479.86%
Market Cap
$10.94M
Net Profit Margin
-620.70%
TTM Avg
-326.13%
3Y Avg
-2493.66%
5Y Avg
-2115.74%
Market Cap
$11.12M
Net Profit Margin
-2702.64%
TTM Avg
-8035.59%
3Y Avg
1817.42%
5Y Avg
219.40%
Market Cap
$10.68M
Net Profit Margin
-2406.00%
TTM Avg
-2017.47%
3Y Avg
-5077.56%
5Y Avg
-6322.50%
Market Cap
$11.36M
Net Profit Margin
-666037.76%
TTM Avg
-148948.78%
3Y Avg
-148948.78%
5Y Avg
-148948.78%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lisata Therapeutics, Inc. (LSTA) | $11.02M | -14621.00% | -1921.94% | 0.00% | 0.00% |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.00M | N/A | -2424.09% | -1624.47% | -1082.98% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.08M | 0.00% | 11.23% | 5.62% | -9479.86% |
| Cerenome, Inc. (CNSY)vs › | $10.94M | -620.70% | -326.13% | -2493.66% | -2115.74% |
| VistaGen Therapeutics, Inc. (VTGN)vs › | $11.12M | -2702.64% | -8035.59% | 1817.42% | 219.40% |
| BioVie Inc. (BIVI)vs › | $10.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Polyrizon Ltd. (PLRZ)vs › | $10.83M | N/A | 0.00% | 0.00% | 0.00% |
| Pluri Inc. (PLUR)vs › | $10.68M | -2406.00% | -2017.47% | -5077.56% | -6322.50% |
| Caring Brands, Inc. (CABR)vs › | $11.36M | -666037.76% | -148948.78% | -148948.78% | -148948.78% |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.55M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-10711.2%
Net Profit Margin
-14621.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | -2954.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | -6655.71% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | -461.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | -143150.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | -118.14% |
| 2016-12-31 | -58.55% |
| 2016-09-30 | -73.88% |
| 2016-06-30 | -94.39% |
| 2016-03-31 | -159.98% |
| 2015-12-31 | -439.11% |
| 2015-09-30 | -193.21% |
| 2015-06-30 | -291.90% |
| 2015-03-31 | -604.89% |
| 2014-12-31 | -220.05% |
| 2014-09-30 | -412.19% |
| 2014-06-30 | -280.80% |
| 2014-03-31 | -337.33% |
| 2013-12-31 | -307.38% |
| 2013-09-30 | -536.75% |
| 2013-06-30 | -196.72% |
| 2013-03-31 | -348.69% |
| 2012-12-31 | -563.61% |
| 2012-09-30 | -189.69% |
| 2012-06-30 | -608.10% |
| 2012-03-31 | -42.38% |
| 2011-12-31 | -105.53% |
| 2011-09-30 | -41.37% |
| 2011-06-30 | -57.45% |
| 2011-03-31 | -51.79% |
| 2010-12-31 | -34.13% |
| 2010-09-30 | -43.34% |
| 2010-06-30 | -27.68% |
| 2010-03-31 | -29.13% |
| 2009-12-31 | -100.77% |
| 2009-09-30 | -8486.50% |
| 2009-06-30 | -14846.09% |
| 2009-03-31 | -4136.74% |
| 2008-12-31 | -7136.05% |
| 2008-09-30 | -7611.35% |
| 2008-06-30 | -10038.14% |
| 2008-03-31 | -364673.74% |
| 2007-12-31 | -1490.67% |
| 2007-09-30 | -34458.52% |
| 2007-06-30 | -32545.47% |
| 2007-03-31 | -3249.55% |
| 2006-12-31 | -6895.26% |
| 2006-09-30 | -28861.50% |
| 2006-06-30 | -19883.14% |
| 2006-03-31 | -18196.17% |
| 2005-12-31 | -7462.85% |
| 2005-09-30 | -7001.11% |
| 2005-06-30 | -4160.31% |
| 2005-03-31 | -2369.91% |
| 2004-12-31 | -2679.29% |
| 2004-09-30 | -16863.04% |
| 2004-06-30 | -6958.57% |
| 2004-03-31 | -1668.52% |
| 2003-12-31 | -3137.81% |
| 2003-09-30 | -1333.61% |
| 2003-06-30 | -1455.96% |
| 2003-03-31 | -794.16% |
| 2002-12-31 | -2032.06% |
| 2002-09-30 | -1095.97% |
